Combating the Growing Burden of Diabetes in India. India is home to over 77 million people living with diabetes, making major contributor to the global diabetes epidemic. By 2030, this number is expected to surge to 101 million. Furthermore, a staggering 40% of Indians with diabetes remain undiagnosed. At Cytech Pharmaceuticals, we are dedicated to addressing this pressing health concern through our comprehensive anti-diabetes portfolio.
Diabetes Product List
| Sr.No. | Product/Brand Name | Composition |
|---|---|---|
| 1 | Techglim -M1 | Glimipiride 1 mg +Metformin (SR) 500 mg Tablets |
| 2 | Techglim-M1 Forte | Glimipiride 1 mg +Metformin (SR) 1000 mg Tablets |
| 3 | Techglim -M2 | Glimipiride 2 mg +Metformin (SR) 500 mg Tablets |
| 4 | Techglim-M2 Forte | Glimipiride 2 mg +Metformin (SR) 1000 mg Tablets |
| 5 | Techglim-MP1 | Glimipiride 1 mg + Metformin (SR) 500 mg + Pioglitazone 15 mg Tablets |
| 6 | Techglim-MP2 | Glimipiride 2 mg +Metformin (SR) 500 mg + Pioglitazone 15 mg Tablets |
| 7 | Techglim-MV 1 0.2 | Glimipiride 1 mg +Metformin (SR) 500 mg + Voglibose 0.2 mg Tablets |
| 8 | Techglim- MV 2 0.2 | Glimipiride 2 mg +Metformin (SR) 500 mg + Voglibose 0.2 mg Tablets |
| 9 | Linacret 5 | Linagliptin 5 mg Tablets |
| 10 | Linacret 2.5 M | Linagliptin 2.5 mg + Metformin 500 mg Tablets |
| 11 | Linacret 2.5 M Forte | Linagliptin 2.5 mg + Metformin 1000 mg Tablets |
| 12 | Linacret D | Linagliptin 5 mg + Dapagliflozin 10 mg Tablets |
| 13 | Dapatech 5 | Dapagliflozin 5 mg Tablets |
| 14 | Dapatech 10 | Dapagliflozin 10 mg Tablets |
| 15 | Dapatech 10 M | Dapagliflozin 10 mg + Metformin 500 mg Tablets |
| 16 | Dapatech 10 M Forte | Dapagliflozin 10 mg + Metformin 1000 mg Tablets |
